Intellia Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.4M | 275k | 30.49 |
| 2023-09-30 | $3.9M | 124k | 31.62 |
| 2023-06-30 | $5.5M | 135k | 40.78 |
| 2023-03-31 | $3.3M | 89k | 37.27 |
| 2022-12-31 | $6.3M | 182k | 34.89 |
| 2022-09-30 | $2.7M | 49k | 55.98 |
| 2022-06-30 | $2.4M | 47k | 51.75 |
| 2022-03-31 | $9.7M | 133k | 72.68 |
| 2021-12-31 | $14M | 115k | 118.24 |
| 2021-09-30 | $8.6M | 65k | 134.15 |
| 2021-06-30 | $8.0M | 49k | 161.91 |
| 2021-03-31 | $4.2M | 52k | 80.25 |
| 2020-12-31 | $6.9M | 126k | 54.40 |
| 2020-09-30 | $1.5M | 76k | 19.88 |
| 2020-06-30 | $1.8M | 86k | 21.02 |
| 2020-03-31 | $999k | 82k | 12.23 |
| 2019-12-31 | $1.7M | 115k | 14.67 |
| 2019-09-30 | $3.0M | 226k | 13.35 |
| 2019-06-30 | $2.5M | 154k | 16.37 |
| 2019-03-31 | $2.4M | 141k | 17.07 |
| 2018-12-31 | $2.8M | 205k | 13.65 |
| 2018-09-30 | $3.9M | 138k | 28.59 |
| 2018-06-30 | $3.3M | 121k | 27.36 |
| 2018-03-31 | $4.0M | 192k | 21.09 |
| 2017-12-31 | $1.6M | 83k | 19.25 |
| 2017-09-30 | $1.7M | 70k | 24.85 |
| 2017-06-30 | $997k | 62k | 16.00 |
| 2017-03-31 | $859k | 61k | 14.10 |
| 2016-12-31 | $150k | 12k | 13.07 |
| 2016-09-30 | $24k | 1.4k | 16.94 |
| 2016-06-30 | $21k | 1.0k | 21.00 |